Clinical Trial Update: Effect of Sevoflurane and Desflurane on Heme Oxygenase-1 Expression in Elective Cholecystectomy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effects of sevoflurane and desflurane on heme oxygenase-1 expression during elective cholecystectomy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholecystitis

Drugs mentioned

• DESFLURANE (DESFLURANE)
• Sevoflurane (Sevoflurane)

Snippet

Sponsor: Kocaeli City Hospital | Conditions: Cholecystitis, Chronic | Phase 4 | Status: WITHDRAWN